Loading Events

« All Events

  • This event has passed.

Fn*A: Unblocking Government Brakes on Innovation (Salon and Dinner)

April 19, 2014 @ 7:00 am - 10:00 pm

(n* representing any variable)

Whether its phone apps for health, or drone apps for delivery, biologic replacement for manufactured product.   As technology accelerates faster than regulators can possibly keep up, Federal agencies and innovators are at odds.   Some of it stems from philosophical orientation: do consumers and citizens have rights to their information, rights to innovate, or do they need to be protected?

FAA:  3/16, Wall Street Journal  “This month a federal administrative judge held that the FAA has no legal authority to meddle in the market and dismissed a fine levied against an operator who defied regulators by getting paid to use a drone to film the University of Virginia campus. Judge Patrick Geraghty of the National Transportation Safety Board ruled that the agency had only issued internal guidance on drones and hadn’t followed any process to apply restrictions to the public. He ridiculed the FAA’s broad assertion of power to regulate drones by saying the agency could use the same argument arbitrarily to block “a flight in the air of a paper aircraft, or a toy balsa wood glider.”

“The FAA has appealed, still intent on grounding one of the most promising new industries made possible by the Internet. Instead of approving the safe use of drones, regulators have undermined innovation to block a new technology. The FAA has allowed only two commercial uses of drones, both in the remote Arctic off Alaska. Congress got fed up with agency foot-dragging and in 2010 passed a law ordering the agency to issue rules making drones legal for commercial use by 2015. The agency says it won’t meet the deadline.”

FDA:  3/13/14, LA Times:  “When the Food & Drug Administration last November ordered the Mountain View, Calif.-based firm 23andMe to stop marketing its health-related genetic test kit to consumers, the ensuing debate took on a “rage against the machine” tenor. Entrepreneurs, patients’ rights advocates and genetics geeks across the country argued that the plodding, risk-averse regulators of the FDA had neither the right nor the expertise to insert themselves between people wishing to own whatever mysteries their genes contained, and a company that promised to deliver such information.”

email christine@sweetmedia.us for an invitation.



April 19, 2014
7:00 am - 10:00 pm
Event Category: